149 related articles for article (PubMed ID: 21658724)
1. Breast MRI utilization in older patients with newly diagnosed breast cancer.
Sommer CA; Stitzenberg KB; Tolleson-Rinehart S; Carpenter WR; Carey TS
J Surg Res; 2011 Sep; 170(1):77-83. PubMed ID: 21658724
[TBL] [Abstract][Full Text] [Related]
2. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer.
Henderson LM; Weiss J; Hubbard RA; O'Donoghue C; DeMartini WB; Buist DS; Kerlikowske K; Goodrich M; Virnig B; Tosteson AN; Lehman CD; Onega T
Breast J; 2016; 22(1):24-34. PubMed ID: 26511204
[TBL] [Abstract][Full Text] [Related]
4. Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer.
Killelea BK; Long JB; Chagpar AB; Ma X; Soulos PR; Ross JS; Gross CP
Breast Cancer Res Treat; 2013 Aug; 141(1):155-63. PubMed ID: 23942872
[TBL] [Abstract][Full Text] [Related]
5. Variability of preoperative breast MRI utilization among older women with newly diagnosed early-stage breast cancer.
Wang SY; Virnig BA; Tuttle TM; Jacobs DR; Kuntz KM; Kane RL
Breast J; 2013; 19(6):627-36. PubMed ID: 24011145
[TBL] [Abstract][Full Text] [Related]
6. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
8. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
[TBL] [Abstract][Full Text] [Related]
9. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
10. Causes of death and relative survival of older women after a breast cancer diagnosis.
Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
[TBL] [Abstract][Full Text] [Related]
11. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer.
van la Parra RFD; Liao K; Smith BD; Yang WT; Leung JWT; Giordano SH; Kuerer HM
JAMA Surg; 2018 Jun; 153(6):559-568. PubMed ID: 29387884
[TBL] [Abstract][Full Text] [Related]
13. Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortality.
Wang SY; Long JB; Killelea BK; Evans SB; Roberts KB; Silber AL; Davidoff AJ; Sedghi T; Gross CP
Breast Cancer Res Treat; 2018 Nov; 172(2):453-461. PubMed ID: 30099634
[TBL] [Abstract][Full Text] [Related]
14. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
[No Abstract] [Full Text] [Related]
15. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
[TBL] [Abstract][Full Text] [Related]
16. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
17. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
[TBL] [Abstract][Full Text] [Related]
18. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.
Riley GF; Potosky AL; Klabunde CN; Warren JL; Ballard-Barbash R
JAMA; 1999 Feb; 281(8):720-6. PubMed ID: 10052442
[TBL] [Abstract][Full Text] [Related]
19. Long-term Impact of CALGB 9343 on Radiation Utilization.
Squeo G; Malpass JK; Meneveau M; Balkrishnan R; Desai RP; Lattimore C; Anderson RT; Showalter SL
J Surg Res; 2020 Dec; 256():577-583. PubMed ID: 32805580
[TBL] [Abstract][Full Text] [Related]
20. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]